Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk
Copenhagen, Denmark — Danish pharma group Novo Nordisk’s obesity drug Wegovy cuts the risk of heart attacks and strokes by a fifth, the company said in an announcement Tuesday that sent its shares soaring to a record high. Though preliminary, it is the first research to suggest this class of weight loss medication, which has attracted […]
The post Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.